Close

Roth Comments on Regeneron (REGN), Sanofi Presentation of Sarilumab Phase 3 Data; Affirms at 'Buy'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. TSLA
5. SPY
6. INFY
7. SNV
8. SMCI
9. SLB
10. PPG


Go back to Roth Comments on Regeneron (REGN), Sanofi Presentation of Sarilumab Phase 3 Data; Affirms at 'Buy'
Regeneron (NASDAQ: REGN) Delayed: 896.82 +2.83 (0.32%)
Previous Close $893.99    52 Week High $592.36 
Open $913.97    52 Week Low $325.35 
Day High $920.73    P/E 235.39 
Day Low $891.46    EPS $3.81 
Volume 507,467